House Committee holds hearings on sky-rocketing price for children's allergy medicine
Mylan Inc. CEO Heather Bresch points to a graph chart showing the company's EpiPen cost vs average revenue as she testifies before the House Oversight and Government Reform Committee, on Capitol Hill in Washington, DC, September 21, 2016. The committee is investigating the sky-rocketing price of the life-saving children's allergy medicine. Photo by Mike Theiler/UPI
Please fill out form for pricing information for the photo below.